|
RAB38 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.26005888950931E-12 |
| Normal-vs-Stage2 |
1.98458999999263E-05 |
| Normal-vs-Stage3 |
8.563400E-04 |
| Normal-vs-Stage4 |
1.016490E-02 |
| Stage1-vs-Stage2 |
5.592400E-02 |
| Stage1-vs-Stage3 |
1.324960E-01 |
| Stage1-vs-Stage4 |
1.295780E-01 |
| Stage2-vs-Stage3 |
8.233200E-01 |
| Stage2-vs-Stage4 |
4.247000E-01 |
| Stage3-vs-Stage4 |
6.573000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62747593179802E-12 |
| Normal-vs-AfricanAmerican |
5.98029999965277E-08 |
| Normal-vs-Asian |
9.444300E-02 |
| Caucasian-vs-AfricanAmerican |
8.111800E-01 |
| Caucasian-vs-Asian |
1.266610E-01 |
| AfricanAmerican-vs-Asian |
3.837000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.93789428948321E-12 |
| Normal-vs-Female |
5.52335954751015E-13 |
| Male-vs-Female |
2.116000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.09850000207246E-08 |
| Normal-vs-Extreme_Weight |
3.08999999998338E-06 |
| Normal-vs-Obese |
1.38129999660563E-08 |
| Normal-vs-Extreme_Obese |
2.956200E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.422630E-01 |
| Normal_Weight-vs-Obese |
6.217400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.197800E-01 |
| Extreme_Weight-vs-Obese |
5.012300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.847000E-01 |
| Obese-vs-Extreme_Obese |
9.477800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.376140E-02 |
| Normal-vs-Age(41-60Yrs) |
8.74100791747878E-12 |
| Normal-vs-Age(61-80Yrs) |
1.66378022470326E-12 |
| Normal-vs-Age(81-100Yrs) |
1.980960E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.489410E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.022400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.024200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.392190E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.820960E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.854400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.43565192856477E-13 |
| Normal-VS-Type2 PRCC |
2.23249999597996E-08 |
| Normal-VS-KIRP CIMP |
4.236300E-03 |
| Normal-VS-Unclassified PRCC |
1.440330E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.208500E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.676400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.040150E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.348300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.474200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.307200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.583500E-04 |
| Normal-vs-N1 |
1.420900E-04 |
| Normal-vs-N2 |
6.092500E-02 |
| N0-vs-N1 |
9.923000E-01 |
| N0-vs-N2 |
7.852600E-01 |
| N1-vs-N2 |
6.530800E-01 |
|
|
